指南&解读

订阅

MedSci主页 / 所有栏目 / 指南&解读

APASL慢性乙型肝炎管理指南(2008版)

2010-08-23 MedSci原创 MedSci原创

乙型肝炎
关注

APASL慢性乙型肝炎管理指南(2008版).doc

APASL慢性乙型肝炎管理指南(2008版).doc

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2011-06-13 okhuali

    #乙型肝炎#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2011-07-12 ms3830150583600765

    #管理指南#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2010-08-25 guguangxiang

    #慢性乙型肝炎#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2010-08-25 12498b3em08(暂无昵称)

    #APA#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2010-08-25 lq1771

    #ASL#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1825564, encodeId=b1ce182556429, content=<a href='/topic/show?id=1a942339426' target=_blank style='color:#2F92EE;'>#乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23394, encryptionId=1a942339426, topicName=乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ea6321, createdName=okhuali, createdTime=Mon Jun 13 12:33:00 CST 2011, time=2011-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1936241, encodeId=33c019362417d, content=<a href='/topic/show?id=daa1e60387b' target=_blank style='color:#2F92EE;'>#管理指南#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76038, encryptionId=daa1e60387b, topicName=管理指南)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIUEDhSibBFt8TicgFCCSBtW10SxVJicDpibTCucns8L1YaiaKpibWOkv8hYpJ0LeTVUH1Ab4sfica9bxiccA/132, createdBy=dd282500126, createdName=ms3830150583600765, createdTime=Tue Jul 12 07:33:00 CST 2011, time=2011-07-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1271216, encodeId=acae12e121685, content=<a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53463, encryptionId=3d745346316, topicName=慢性乙型肝炎)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1338103, encodeId=2b3f1338103db, content=<a href='/topic/show?id=cd2a262068' target=_blank style='color:#2F92EE;'>#APA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2620, encryptionId=cd2a262068, topicName=APA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce072500140, createdName=12498b3em08(暂无昵称), createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1519115, encodeId=aa711519115df, content=<a href='/topic/show?id=2082286e7b' target=_blank style='color:#2F92EE;'>#ASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2867, encryptionId=2082286e7b, topicName=ASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c1a311248160, createdName=lq1771, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1598419, encodeId=ace01598419ed, content=<a href='/topic/show?id=a8952625e5' target=_blank style='color:#2F92EE;'>#APASL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2625, encryptionId=a8952625e5, topicName=APASL)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b18118584502, createdName=tongyongming, createdTime=Wed Aug 25 13:33:00 CST 2010, time=2010-08-25, status=1, ipAttribution=)]
    2010-08-25 tongyongming

    #APASL#

    0

相关资讯

《慢性乙型肝炎防治指南》专家讨论会纪要

《慢性乙型肝炎防治指南》专家讨论会纪要.doc